Hartford Healthcare Cancer Institute

Hartford, Connecticut 06106

2 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia (AML), Bladder Cancer, Chemotherapy-induced Peripheral Neuropathy, Coronavirus, Gynecologic Cancer, Metastatic Urothelial Carcinoma, Muscle Invasive Bladder Cancer, Neoplasms, Renal Pelvis Carcinoma, Ureter Carcinoma, Urethra Carcinoma, Urinary Bladder Carcinoma

Studies at this site

• Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML — Recruiting now
• Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2 — Recruiting now
• ASCO Survey on COVID-19 in Oncology (ASCO) Registry — Status unconfirmed
• Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma — Stopped early